Literature DB >> 24867951

Activated hepatic stellate cells are dependent on self-collagen, cleaved by membrane type 1 matrix metalloproteinase for their growth.

Naoko Kubo Birukawa1, Kazuyuki Murase2, Yasushi Sato2, Akemi Kosaka1, Akihiro Yoneda1, Hiroki Nishita1, Ryosuke Fujita1, Miyuki Nishimura1, Takafumi Ninomiya3, Keiko Kajiwara4, Miyono Miyazaki4, Yusuke Nakashima1, Sigenori Ota1, Yuya Murakami1, Yasunobu Tanaka4, Kenjiro Minomi4, Yasuaki Tamura5, Yoshiro Niitsu6.   

Abstract

Stellate cells are distributed throughout organs, where, upon chronic damage, they become activated and proliferate to secrete collagen, which results in organ fibrosis. An intriguing property of hepatic stellate cells (HSCs) is that they undergo apoptosis when collagen is resolved by stopping tissue damage or by treatment, even though the mechanisms are unknown. Here we disclose the fact that HSCs, normal diploid cells, acquired dependence on collagen for their growth during the transition from quiescent to active states. The intramolecular RGD motifs of collagen were exposed by cleavage with their own membrane type 1 matrix metalloproteinase (MT1-MMP). The following evidence supports this conclusion. When rat activated HSCs (aHSCs) were transduced with siRNA against the collagen-specific chaperone gp46 to inhibit collagen secretion, the cells underwent autophagy followed by apoptosis. Concomitantly, the growth of aHSCs was suppressed, whereas that of quiescent HSCs was not. These in vitro results are compatible with the in vivo observation that apoptosis of aHSCs was induced in cirrhotic livers of rats treated with siRNAgp46. siRNA against MT1-MMP and addition of tissue inhibitor of metalloproteinase 2 (TIMP-2), which mainly inhibits MT1-MMP, also significantly suppressed the growth of aHSCs in vitro. The RGD inhibitors echistatin and GRGDS peptide and siRNA against the RGD receptor αVβ1 resulted in the inhibition of aHSCs growth. Transduction of siRNAs against gp46, αVβ1, and MT1-MMP to aHSCs inhibited the survival signal of PI3K/AKT/IκB. These results could provide novel antifibrosis strategies.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Apoptosis; Extracellular Matrix; Fibrosis; Heat Shock Protein (HSP); Integrin

Mesh:

Substances:

Year:  2014        PMID: 24867951      PMCID: PMC4106337          DOI: 10.1074/jbc.M113.544494

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

Review 1.  Mechanisms of disease: Oncogene addiction--a rationale for molecular targeting in cancer therapy.

Authors:  I Bernard Weinstein; Andrew K Joe
Journal:  Nat Clin Pract Oncol       Date:  2006-08

Review 2.  Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies.

Authors:  S L Friedman
Journal:  N Engl J Med       Date:  1993-06-24       Impact factor: 91.245

3.  Inhibition of inhibitor of kappaB kinases stimulates hepatic stellate cell apoptosis and accelerated recovery from rat liver fibrosis.

Authors:  Fiona Oakley; Muriel Meso; John P Iredale; Karen Green; Carylyn J Marek; Xiaoying Zhou; Michael J May; Harry Millward-Sadler; Matthew C Wright; Derek A Mann
Journal:  Gastroenterology       Date:  2005-01       Impact factor: 22.682

4.  Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors.

Authors:  J P Iredale; R C Benyon; J Pickering; M McCullen; M Northrop; S Pawley; C Hovell; M J Arthur
Journal:  J Clin Invest       Date:  1998-08-01       Impact factor: 14.808

5.  Active matrix metalloproteinase-2 promotes apoptosis of hepatic stellate cells via the cleavage of cellular N-cadherin.

Authors:  Stephen N Hartland; Frank Murphy; Rebecca L Aucott; Armand Abergel; Xiaoying Zhou; Julian Waung; Nishit Patel; Catherine Bradshaw; Jane Collins; Derek Mann; R Christopher Benyon; John P Iredale
Journal:  Liver Int       Date:  2009-08       Impact factor: 5.828

6.  Treatment of pancreatic fibrosis with siRNA against a collagen-specific chaperone in vitamin A-coupled liposomes.

Authors:  Hirotoshi Ishiwatari; Yasushi Sato; Kazuyuki Murase; Akihiro Yoneda; Ryosuke Fujita; Hiroki Nishita; Naoko Kubo Birukawa; Tsuyoshi Hayashi; Tsutomu Sato; Koji Miyanishi; Rishu Takimoto; Masayoshi Kobune; Shigenori Ota; Yasutoshi Kimura; Koichi Hirata; Junji Kato; Yoshiro Niitsu
Journal:  Gut       Date:  2012-11-20       Impact factor: 23.059

7.  Silencing tissue inhibitors of metalloproteinases (TIMPs) with short interfering RNA reveals a role for TIMP-1 in hepatic stellate cell proliferation.

Authors:  Andrew J Fowell; Jane E Collins; Dale R Duncombe; Judith A Pickering; William M C Rosenberg; R Christopher Benyon
Journal:  Biochem Biophys Res Commun       Date:  2011-02-15       Impact factor: 3.575

8.  Impaired proteolysis of collagen I inhibits proliferation of hepatic stellate cells: implications for regulation of liver fibrosis.

Authors:  Xiaoying Zhou; Aqeel Jamil; Andrew Nash; James Chan; Nathan Trim; John P Iredale; R Christopher Benyon
Journal:  J Biol Chem       Date:  2006-10-23       Impact factor: 5.157

9.  Heat shock protein 90-mediated inactivation of nuclear factor-κB switches autophagy to apoptosis through becn1 transcriptional inhibition in selenite-induced NB4 cells.

Authors:  Qian Jiang; Yuhan Wang; Tianjiao Li; Kejian Shi; Zhushi Li; Yushi Ma; Feng Li; Hui Luo; Yang Yang; Caimin Xu
Journal:  Mol Biol Cell       Date:  2011-02-23       Impact factor: 4.138

10.  Plasma and cellular fibronectin: distinct and independent functions during tissue repair.

Authors:  Wing S To; Kim S Midwood
Journal:  Fibrogenesis Tissue Repair       Date:  2011-09-16
View more
  8 in total

1.  Endoplasmic reticulum oxidase 1α is critical for collagen secretion from and membrane type 1-matrix metalloproteinase levels in hepatic stellate cells.

Authors:  Mizuki Fujii; Akihiro Yoneda; Norio Takei; Kaori Sakai-Sawada; Marina Kosaka; Kenjiro Minomi; Atsuro Yokoyama; Yasuaki Tamura
Journal:  J Biol Chem       Date:  2017-08-03       Impact factor: 5.157

Review 2.  Genetic and epigenetic regulation of intestinal fibrosis.

Authors:  Chao Li; John F Kuemmerle
Journal:  United European Gastroenterol J       Date:  2016-07-14       Impact factor: 4.623

Review 3.  Emerging strategies to disrupt the central TGF-β axis in kidney fibrosis.

Authors:  Michael Rauchman; David Griggs
Journal:  Transl Res       Date:  2019-04-24       Impact factor: 7.012

4.  High throughput interrogation of human liver stellate cells reveals microenvironmental regulation of phenotype.

Authors:  Aidan Brougham-Cook; Ishita Jain; David A Kukla; Faisal Masood; Hannah Kimmel; Hyeon Ryoo; Salman R Khetani; Gregory H Underhill
Journal:  Acta Biomater       Date:  2021-11-17       Impact factor: 8.947

5.  Hepatic stellate cells derived from the nestin-positive cells in septum transversum during rat liver development.

Authors:  Makoto Toi; Yoshihiro Hayashi; Ichiro Murakami
Journal:  Med Mol Morphol       Date:  2018-01-29       Impact factor: 2.309

Review 6.  Fibrosis Regression After Eradication of Hepatitis C Virus: From Bench to Bedside.

Authors:  Don C Rockey; Scott L Friedman
Journal:  Gastroenterology       Date:  2021-01-30       Impact factor: 22.682

7.  CREB3L2-mediated expression of Sec23A/Sec24D is involved in hepatic stellate cell activation through ER-Golgi transport.

Authors:  Shotaro Tomoishi; Shinichi Fukushima; Kentaro Shinohara; Toshiaki Katada; Kota Saito
Journal:  Sci Rep       Date:  2017-08-11       Impact factor: 4.379

8.  Involvement of Pancreatic Stellate Cells in Regeneration of Remnant Pancreas after Partial Pancreatectomy.

Authors:  Shigenori Ota; Miyuki Nishimura; Yuya Murakami; Naoko Kubo Birukawa; Akihiro Yoneda; Hiroki Nishita; Ryosuke Fujita; Yasushi Sato; Kenjiro Minomi; Keiko Kajiwara; Miyono Miyazaki; Maki Uchiumi; Shintaro Mikuni; Yasuaki Tamura; Toru Mizuguchi; Masafumi Imamura; Makoto Meguro; Yasutoshi Kimura; Koichi Hirata; Yoshiro Niitsu
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.